000212543 001__ 212543
000212543 005__ 20241219120841.0
000212543 0247_ $$2doi$$a10.1002/cncr.34663
000212543 0247_ $$2pmid$$apmid:36715017
000212543 0247_ $$2ISSN$$a1934-662X
000212543 0247_ $$2ISSN$$a0008-543X
000212543 0247_ $$2ISSN$$a1097-0142
000212543 0247_ $$2ISSN$$a1934-6638
000212543 0247_ $$2altmetric$$aaltmetric:141937809
000212543 037__ $$aDKFZ-2023-00228
000212543 041__ $$aEnglish
000212543 082__ $$a610
000212543 1001_ $$0P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aHemminki, Kari$$b0$$eFirst author$$udkfz
000212543 245__ $$aAutoimmune diseases as comorbidities for liver, gallbladder, and biliary duct cancers in Sweden.
000212543 260__ $$aNew York, NY$$bWiley-Liss$$c2023
000212543 3367_ $$2DRIVER$$aarticle
000212543 3367_ $$2DataCite$$aOutput Types/Journal article
000212543 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1732702732_23889
000212543 3367_ $$2BibTeX$$aARTICLE
000212543 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000212543 3367_ $$00$$2EndNote$$aJournal Article
000212543 500__ $$a#EA:C020# / Volume129, Issue 8, 15 April 2023, Pages 1227-1236
000212543 520__ $$aAutoimmune diseases are associated with many cancers but there is a lack of population-based studies with different autoimmune diseases that have a long follow-up. This is also true of hepatobiliary cancers, which include hepatocellular cancer (HCC) and rarer entities of gallbladder cancer (GBC), intra- and extrahepatic cholangiocarcinoma (iCCA and eCCA), and ampullary cancer.Diagnostic data on 43 autoimmune diseases were collected from the Swedish Inpatient Register from 1987 to 2018, and cancer data were derived from the national cancer registry from 1997 onward. Relative risks were expressed as standardized incidence ratios (SIRs).In a population of 13.6 million, 1.1 million autoimmune diseases were diagnosed and subsequent hepatobiliary cancer was diagnosed in 3191 patients (17.2% of cancers). SIRs for HCC were 2.73 (men) and 2.86 (women), 3.74/1.96 for iCCA, 2.65/1.37 for GBC, 2.38/1.64 for eCCA, and 1.80/1.85 for ampullary cancer. Significant associations between autoimmune disease and HCC were observed for 13 autoimmune diseases, with the highest risks being for autoimmune hepatitis (48.92/73.53, men/women) and primary biliary cirrhosis (38.03/54.48). GBC was increased after six autoimmune diseases, with high SIRs for ulcerative colitis (12.22/3.24) and men with Crohn disease (9.16). These autoimmune diseases were also associated with a high risk of iCCA, which had seven other associations, and eCCA, which had five other associations. Ampullary cancer occurrence was increased after four autoimmune diseases.An autoimmune disease is a common precursor condition for hepatobiliary cancers. This calls for careful control of autoimmune disease symptoms in each patient and encouragement to practice a healthy lifestyle.
000212543 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000212543 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000212543 650_7 $$2Other$$acomorbidity
000212543 650_7 $$2Other$$adischarge data
000212543 650_7 $$2Other$$ahepatocellular cancer
000212543 650_7 $$2Other$$aimmune disturbance
000212543 650_7 $$2Other$$arisk factor
000212543 7001_ $$aSundquist, Kristina$$b1
000212543 7001_ $$aSundquist, Jan$$b2
000212543 7001_ $$0P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aFörsti, Asta$$b3$$udkfz
000212543 7001_ $$aLiska, Vaclav$$b4
000212543 7001_ $$aHemminki, Akseli$$b5
000212543 7001_ $$aLi, Xinjun$$b6
000212543 773__ $$0PERI:(DE-600)1479932-7$$a10.1002/cncr.34663$$gp. cncr.34663$$n8$$p1227-1236$$tCancer$$v129$$x0008-543x$$y2023
000212543 8767_ $$82022 (V10366)$$92022-06-23$$d2024-12-19$$eHybrid-OA$$jZahlung erfolgt
000212543 909CO $$ooai:inrepo02.dkfz.de:212543$$pVDB$$pOpenAPC$$popenCost
000212543 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000212543 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f26164c08f2f14abcf31e52e13ee3696$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000212543 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000212543 9141_ $$y2023
000212543 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2022-11-29$$wger
000212543 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2022-11-29
000212543 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-29
000212543 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-29
000212543 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000212543 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000212543 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000212543 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-21
000212543 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000212543 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-21
000212543 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-21
000212543 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCER-AM CANCER SOC : 2022$$d2023-10-21
000212543 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-21
000212543 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-21
000212543 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCER-AM CANCER SOC : 2022$$d2023-10-21
000212543 915pc $$0PC:(DE-HGF)0000$$2APC$$aAPC keys set
000212543 915pc $$0PC:(DE-HGF)0001$$2APC$$aLocal Funding
000212543 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000212543 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x1
000212543 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000212543 9200_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000212543 980__ $$ajournal
000212543 980__ $$aVDB
000212543 980__ $$aI:(DE-He78)C020-20160331
000212543 980__ $$aI:(DE-He78)B062-20160331
000212543 980__ $$aI:(DE-He78)HD01-20160331
000212543 980__ $$aUNRESTRICTED
000212543 980__ $$aAPC